Press Release: Trtllc : TISSUE REGENERATION TECHNOLOGIES Announces That Its First Coronavirus Clinical Trial Has Been Initiated Utilizing Unfocused Shockwave Therapy (SoftWaves)
/PRNewswire/ -- Tissue Regeneration Technologies (TRT) announced today an important addition to our patent family to potentially aid in the fight against the...
Read full article »
CEO
TRT is a Georgia-based medical technology company that develops and manufactures pressure and shock wave devices for the healthcare industry.
Read more